Syndax Pharmaceuticals Inc (SNDX) financials
Syndax Pharmaceuticals revenue and earnings by year
Syndax Pharmaceuticals's revenue was $172 million in the fiscal year to December 31, 2025, up 627.8% from the year before. Net income was -$285 million, -165.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 73.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 8 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 172 | 24 | 140 | 2 | 2 | 2 | 2 | 1 |
| Revenue growth | 627.8% | -83.1% | 9109.6% | 0.0% | 0.0% | -28.0% | 72.8% | — |
| Gross profit | 165 | 23 | — | — | — | — | — | — |
| Gross margin | 96.0% | 96.5% | — | — | — | — | — | — |
| Operating income | -273 | -340 | 26 | -71 | -58 | -76 | -62 | -44 |
| Operating margin | -158.4% | -1434.4% | 18.8% | -4708.2% | -3792.9% | -5001.7% | -2939.0% | -3587.4% |
| Net income | -285 | -319 | 25 | -77 | -56 | -74 | -61 | -47 |
| Net margin | -165.6% | -1346.1% | 17.8% | -5080.0% | -3694.6% | -4875.5% | -2884.3% | -3858.2% |
| Diluted EPS | -$3.29 | -$3.72 | $0.46 | -$1.88 | -$1.85 | -$2.92 | -$2.91 | — |
| Free cash flow | -323 | -275 | 29 | -71 | -51 | -69 | -47 | -35 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open SNDX in Markets.
How Syndax Pharmaceuticals makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Product | $54.7M | 75.1% |
| Collaboration Revenue | $18.1M | 24.9% |
See also: SNDX returns
No forecast, no recommendation. This page describes Syndax Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.